| - GRCh37:
- Chr19:11488825
- GRCh38:
- Chr19:11378149
| EPOR | Y454* | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr12:111856431
- GRCh38:
- Chr12:111418627
| SH2B3 | A161V | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr12:111855950
- GRCh38:
- Chr12:111418146
| SH2B3 | M1V | Primary familial polycythemia due to EPO receptor mutation | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:111884608
- GRCh38:
- Chr12:111446804
| SH2B3 | W262R, W60R | not provided, Thrombocythemia 1, Primary familial polycythemia due to EPO receptor mutation, Primary myelofibrosis | Benign (May 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:5070058
- GRCh38:
- Chr9:5070058
| INSL6, JAK2 | | Budd-Chiari syndrome, Thrombocythemia 3, Primary myelofibrosis, Acute myeloid leukemia, Primary familial polycythemia due to EPO receptor mutation, Acquired polycythemia vera, not provided, Acquired polycythemia vera | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr19:11493766
- GRCh38:
- Chr19:11383090
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11492698
- GRCh38:
- Chr19:11382022
| EPOR, LOC130063571 | A112V | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11492645
- GRCh38:
- Chr19:11381969
| EPOR, LOC130063570 | A130T | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11492395
- GRCh38:
- Chr19:11381719
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488628
- GRCh38:
- Chr19:11377952
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11492394
- GRCh38:
- Chr19:11381718
| EPOR | G187C | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11491861
- GRCh38:
- Chr19:11381185
| EPOR | E204Q | Primary familial polycythemia due to EPO receptor mutation, Inborn genetic diseases | Uncertain significance (Mar 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11491808
- GRCh38:
- Chr19:11381132
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11489421
- GRCh38:
- Chr19:11378745
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11487884
- GRCh38:
- Chr19:11377208
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11494938
- GRCh38:
- Chr19:11384262
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11494908
- GRCh38:
- Chr19:11384232
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11489381
- GRCh38:
- Chr19:11378705
| EPOR | K301E | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488900
- GRCh38:
- Chr19:11378224
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11494892
- GRCh38:
- Chr19:11384216
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11494871
- GRCh38:
- Chr19:11384195
| EPOR | G5R | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11493918
- GRCh38:
- Chr19:11383242
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488731
- GRCh38:
- Chr19:11378055
| EPOR | S486P | Primary familial polycythemia due to EPO receptor mutation | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488720
- GRCh38:
- Chr19:11378044
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11492737
- GRCh38:
- Chr19:11382061
| EPOR, LOC130063571 | A99V | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign/Likely benign (May 21, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:111885295
- GRCh38:
- Chr12:111447491
| SH2B3 | E193K, E395K | Primary familial polycythemia due to EPO receptor mutation, Thrombocythemia 1 | Pathogenic (Mar 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:111885310
- GRCh38:
- Chr12:111447506
| SH2B3 | E198K, E400K | Primary familial polycythemia due to EPO receptor mutation, Primary myelofibrosis, Thrombocythemia 1, not provided | Uncertain significance (Oct 31, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11494951
- GRCh38:
- Chr19:11384275
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11494891
- GRCh38:
- Chr19:11384215
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11494860
- GRCh38:
- Chr19:11384184
| EPOR | | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign/Likely benign (May 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11494762
- GRCh38:
- Chr19:11384086
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11493887
- GRCh38:
- Chr19:11383211
| EPOR | G46E | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11493856
- GRCh38:
- Chr19:11383180
| EPOR | | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign (Dec 31, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11493809
- GRCh38:
- Chr19:11383133
| EPOR | V72A | Primary familial polycythemia due to EPO receptor mutation | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11492515
- GRCh38:
- Chr19:11381839
| EPOR | | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign (Dec 31, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11492395
- GRCh38:
- Chr19:11381719
| EPOR | | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign/Likely benign (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11492385
- GRCh38:
- Chr19:11381709
| EPOR | A190S | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11491875
- GRCh38:
- Chr19:11381199
| EPOR | L199P | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11491814
- GRCh38:
- Chr19:11381138
| EPOR | | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign (Dec 31, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11489418
- GRCh38:
- Chr19:11378742
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11489207
- GRCh38:
- Chr19:11378531
| EPOR | P327L | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11489165
- GRCh38:
- Chr19:11378489
| EPOR | T341M | Primary familial polycythemia due to EPO receptor mutation | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11489146
- GRCh38:
- Chr19:11378470
| EPOR | | Inborn genetic diseases, not provided, Primary familial polycythemia due to EPO receptor mutation
| Benign/Likely benign (Aug 4, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11489049
- GRCh38:
- Chr19:11378373
| EPOR | P380A | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign (Jun 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11489048
- GRCh38:
- Chr19:11378372
| EPOR | P380L | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488789
- GRCh38:
- Chr19:11378113
| EPOR | | not provided, Primary familial polycythemia due to EPO receptor mutation | Benign (May 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11488760
- GRCh38:
- Chr19:11378084
| EPOR | A476V | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488759
- GRCh38:
- Chr19:11378083
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488743
- GRCh38:
- Chr19:11378067
| EPOR | D482N | Primary familial polycythemia due to EPO receptor mutation, Inborn genetic diseases | Likely benign (Oct 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11488625
- GRCh38:
- Chr19:11377949
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488235
- GRCh38:
- Chr19:11377559
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488156
- GRCh38:
- Chr19:11377480
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488083
- GRCh38:
- Chr19:11377407
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488041
- GRCh38:
- Chr19:11377365
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11487990
- GRCh38:
- Chr19:11377314
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11487976
- GRCh38:
- Chr19:11377300
| EPOR | | Primary familial polycythemia due to EPO receptor mutation | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488871
- GRCh38:
- Chr19:11378195
| EPOR | W439* | Acute megakaryoblastic leukemia without down syndrome | Likely pathogenic (Sep 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:11488725
- GRCh38:
- Chr19:11378049
| EPOR | P488S | Primary familial polycythemia due to EPO receptor mutation, not provided, Intellectual disability-hypotonic facies syndrome, X-linked, 1
| Benign/Likely benign (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11488877
- GRCh38:
- Chr19:11378201
| EPOR | R437H | Primary familial polycythemia due to EPO receptor mutation, not provided | Benign (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:5044432
- GRCh38:
- Chr9:5044432
| INSL6, JAK2 | G127D | Primary myelofibrosis, Thrombocythemia 3, Primary familial polycythemia due to EPO receptor mutation, Acquired polycythemia vera, Budd-Chiari syndrome, Acute myeloid leukemia, not provided | Benign/Likely benign (Jul 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:5126343
- GRCh38:
- Chr9:5126343
| INSL6, JAK2 | R1063H, R658H, R914H | Budd-Chiari syndrome, Primary familial polycythemia due to EPO receptor mutation, Acquired polycythemia vera, Acute myeloid leukemia, Primary myelofibrosis, Thrombocythemia 3, not specified, not provided | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:111856571
- GRCh38:
- Chr12:111418767
| SH2B3 | E208* | Primary familial polycythemia due to EPO receptor mutation | Affects (Sep 16, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr19:11488897-11488898
- GRCh38:
- Chr19:11378221-11378222
| EPOR | S432fs | Primary familial polycythemia due to EPO receptor mutation | Affects (Oct 1, 1999) | no assertion criteria provided |
| - GRCh37:
- Chr19:11488909
- GRCh38:
- Chr19:11378233
| EPOR | Y426* | Primary familial polycythemia due to EPO receptor mutation | Affects (Jul 1, 1998) | no assertion criteria provided |
| - GRCh37:
- Chr19:11488882-11488888
- GRCh38:
- Chr19:11378206-11378212
| EPOR | Q434fs | Primary familial polycythemia due to EPO receptor mutation | Affects (Sep 1, 1997) | no assertion criteria provided |
| - GRCh37:
- Chr19:11488727
- GRCh38:
- Chr19:11378051
| EPOR | N487S | not specified, not provided, Primary familial polycythemia due to EPO receptor mutation
| Benign/Likely benign (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:11488905-11488906
- GRCh38:
- Chr19:11378229-11378230
| EPOR | I428fs | Primary familial polycythemia due to EPO receptor mutation | Affects (Sep 1, 1997) | no assertion criteria provided |
| - GRCh37:
- Chr19:11488898-11488899
- GRCh38:
- Chr19:11378222-11378223
| EPOR | D430fs | Primary familial polycythemia due to EPO receptor mutation | Affects (Jul 1, 1995) | no assertion criteria provided |
| - GRCh37:
- Chr19:11488870
- GRCh38:
- Chr19:11378194
| EPOR | W439* | Primary familial polycythemia due to EPO receptor mutation | Affects (Feb 1, 1998) | no assertion criteria provided |
| - GRCh37:
- Chr9:5073770
- GRCh38:
- Chr9:5073770
| INSL6, JAK2 | V617F, V212F, V468F | Primary familial polycythemia due to EPO receptor mutation, Acute myeloid leukemia, Primary myelofibrosis, Thrombocythemia 3, Budd-Chiari syndrome, Acquired polycythemia vera, Thrombocythemia 3, not provided, Acquired polycythemia vera, Primary myelofibrosis | Pathogenic/Likely pathogenic (Apr 27, 2023) | criteria provided, multiple submitters, no conflicts |